We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

LGC Clinical Diagnostics Demonstrates Lab Solutions and Processes to Enhance QC Efficiencies

By LabMedica International staff writers
Posted on 25 May 2023
Print article
Image: The LGC Clinical Diagnostics team is present at this year\'s WorldLab-EuroMedLab (Photo courtesy of LGC)
Image: The LGC Clinical Diagnostics team is present at this year\'s WorldLab-EuroMedLab (Photo courtesy of LGC)

LGC Clinical Diagnostics (Middlesex, UK) is participating in the 2023 WordLab-EuroMedLab Congress where the company’s quality control experts are demonstrating how automated processes with Multichem independent QC and IAMQC QC data management software can enhance QC efficiencies in the laboratory.

LGC’s brands include three IVD manufacturers of QMTs (Maine Standards Company, SeraCare and Technopath Clinical Diagnostics) and one manufacturer of viral and bacterial antigens and antibodies (The Native Antigen Company). At EuroMedLab 2023, LGC is showcasing various product offerings, including Multichem Independent Quality Control, VALIDATE calibration and verification materials, as well as its leading serology portfolio – ACCURUN, alongside its Clinical Genomics portfolio including Seraseq for NGS.

Technopath’s Multichem Independent Quality Control materials have a broader analyte range, enabling extensive consolidation of the test menu. This results in simplified lab inventory, cost reduction, and increased efficiencies. Its flagship products, Multichem IA Plus and Multichem S Plus, combine to offer over 190 tests. These can replace up to 8 rival products, streamlining lab operations. IAMQC Software, designed to support the Multichem QC product line, offers a suite of QC software tools for lab managers and technologists, allowing real-time QC results analysis. It helps automate, centralize, standardize, and enhance QC processes in labs. Its modules can be customized to cater to the different QC needs of individual labs.

The VALIDATE range of calibration and verification materials from Maine Standards Company are user-friendly kits that help document linearity, calibration verification, and linear range verification, as needed by several inspection bodies. They also aid in troubleshooting instrument systems, reagent issues, and calibration inconsistencies. They are available in a variety of product configurations, specifically formulated to maximize reportable ranges with minimum dilutions.

SeraCare's ACCURUN controls and reference materials are developed to be weakly reactive, providing additional confidence in lab test results. SeraCare’s Seraseq Next-generation sequencing (NGS) reference materials aid in building, validating, implementing, and standardizing superior clinical genomics assays. Its customizable biological materials help diagnostic assay developers build more robust assays swiftly. SeraCare's readily accessible antibodies and immunoassay reagents can accelerate research and IVD assay development.

Related Links:
LGC

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more